Respiratory
Determine™ TB LAM Ag
Saving lives with early TB diagnosis in people living with HIV (PLHIV).
The Determine™ TB LAM Ag test empowers you, at the point-of-care, to screen for active TB in HIV positive patients, providing results in just minutes.
This rapid test detects the LAM antigen (lipoarabinomannan) in urine samples, assisting you in your TB screening to rule-in sooner than traditional methods and enabling earlier treatment for your patient.
Panbio™ COVID-19 Ag Rapid Test Device
Identify potentially contagious patients with or without symptoms in 15 minutes
Patient-friendly, supervised self-collected Nasal swab minimizes health worker exposure. For professional use only.
High performance rapid test enables immediate treatment or isolation measures to minimize transmission.
Accessible, easy-to-deploy, large-scale testing helps contain the virus spread.
Bioline™ TB Ag MPT64
Test to discriminate between M. Tuberculosis complex and MOTT(NTM)
Bioline™ TB Ag MPT64 is a immunochromatographic identification test for the M. Tuberculosis complex. Biochemical, immunological and molecular biological characterization of Mycobacterium tuberculosis has led to the identification of several antigens which may be useful in the development of improved diagnostic methods in order to discriminate between the M. tuberculosis complex and mycobacteria other than M. tuberculosis (MOTT bacilli).
Bioline™ RSV
Test for Respiratory Syncytial Virus infection
Bioline™ RSV test is an immunochromatographic assay for qualitative detection of Respiratory Syncytial Virus (RSV) in NPA (Nasopharyngeal Aspirate).
Bioline™ Strep A
Test for Group A streptococcal infection.
Bioline™ Strep A strip test is a chromatographic immunoassay for the qualitative detection of group A streptococcal antigens directly from throat swabs or confirmation of presumptive Group A Streptococcal colonies recovered from culture. The assay detects either viable or nonviable organisms directly form throat swabs or culture colonies.
Speak with Lifecare Diagnostics about respiratory testing products.
Determine™ TB LAM Ag
Saving lives with early TB diagnosis in people living with HIV (PLHIV).
The Determine™ TB LAM Ag test empowers you, at the point-of-care, to screen for active TB in HIV positive patients, providing results in just minutes.
This rapid test detects the LAM antigen (lipoarabinomannan) in urine samples, assisting you in your TB screening to rule-in sooner than traditional methods and enabling earlier treatment for your patient.
Panbio™ COVID-19 Ag Rapid Test Device
Identify potentially contagious patients with or without symptoms in 15 minutes
Patient-friendly, supervised self-collected Nasal swab minimizes health worker exposure. For professional use only.
High performance rapid test enables immediate treatment or isolation measures to minimize transmission.
Accessible, easy-to-deploy, large-scale testing helps contain the virus spread.
Bioline™ TB Ag MPT64
Test to discriminate between M. Tuberculosis complex and MOTT(NTM)
Bioline™ TB Ag MPT64 is a immunochromatographic identification test for the M. Tuberculosis complex. Biochemical, immunological and molecular biological characterization of Mycobacterium tuberculosis has led to the identification of several antigens which may be useful in the development of improved diagnostic methods in order to discriminate between the M. tuberculosis complex and mycobacteria other than M. tuberculosis (MOTT bacilli). M. tuberculosis has been known to secrete more than 33 different proteins. One of the predominant proteins, MPT64 was found in the culture fluid of only strains of the M. tuberculosis complex.
Bioline™ RSV
Test for Respiratory Syncytial Virus infection
Bioline™ RSV test is an immunochromatographic assay for qualitative detection of Respiratory Syncytial Virus (RSV) in NPA (Nasopharyngeal Aspirate).
Bioline™ Strep A
Test for Group A streptococcal infection.
Bioline™ Strep A strip test is a chromatographic immunoassay for the qualitative detection of group A streptococcal antigens directly from throat swabs or confirmation of presumptive Group A Streptococcal colonies recovered from culture. The assay detects either viable or nonviable organisms directly form throat swabs or culture colonies.
